Cargando…

Adrenal metastasis in sequentially developed combined hepatocellular carcinoma-cholangiocarcinoma: A case report

The incidence of combined hepatocellular carcinoma-cholangiocarcinoma (cHCC-CC) in a single patient accounts for only 0.4 to 14% of all primary liver cancer. However, the prognosis of its intrahepatic cholangiocarcinoma (ICC) component is poor. We experienced a unique case of a sequentially develope...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nugroho, Adianto, Lee, Kwang-Woong, Lee, Kyung-Bun, Kim, Hyo-Shin, Kim, Hyeyoung, Yi, Nam-Joon, Suh, Kyung-Suk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association of Hepato-Biliary-Pancreatic Surgery 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125274/ https://www.ncbi.nlm.nih.gov/pubmed/30215052 http://dx.doi.org/10.14701/ahbps.2018.22.3.287

Ejemplares similares

Posttransplant sequential adrenal and spine metastasis of hepatocellular carcinoma responsive to combined regorafenib and radiotherapy: a case report
por: Kim, Jae-Yoon, et al.
Publicado: (2023)

The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas
por: Lee, KyuHo, et al.
Publicado: (2017)

Bile duct invasion can be an independent prognostic factor in early stage hepatocellular carcinoma
por: Jang, Ye-Rang, et al.
Publicado: (2015)

False Positive Diagnosis of Hepatocellular Carcinoma in Liver Resection Patients
por: Lee, Hongeun, et al.
Publicado: (2017)

Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma
por: Lee, Kyung-Hun, et al.
Publicado: (2015)

Risk Factors for the Adverse Events after Conversion from Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplantation Patients
por: Suh, Suk-Won, et al.
Publicado: (2016)

Peri-Transplant Change in AFP Level: a Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation
por: Yoo, Tae, et al.
Publicado: (2016)

Korean Patients Undergoing Deceased Donor Liver Transplantation for Alcoholic Liver Disease Have Non-Inferior Survival Outcomes than for Hepatitis B Virus: a Real-World Experience without Minimum Abstinence before Transplantation
por: Hong, Suk Kyun, et al.
Publicado: (2017)

Pure laparoscopic right hepatectomy in a patient with situs inversus totalis: A case report
por: Hong, Suk Kyun, et al.
Publicado: (2017)

Clinical impact of the treatment modality on small, solitary, recurrent intrahepatic hepatocellular carcinomas after primary liver resection
por: Kim, Hyo-Sin, et al.
Publicado: (2021)

Long‐term outcomes of laparoscopic versus open liver resection for intrahepatic combined hepatocellular‐cholangiocarcinoma with propensity score matching
por: Lee, Seung Jae, et al.
Publicado: (2022)

Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation
por: Lee, Ju-Yeun, et al.
Publicado: (2014)

Optimal Tailored Screening Protocol after Living Donor Liver Transplantation for Hepatocellular Carcinoma
por: Park, Min-Su, et al.
Publicado: (2014)

Response-Guided Therapy for Hepatitis C Virus Recurrence Based on Early Protocol Biopsy after Liver Transplantation
por: Kim, Hyeyoung, et al.
Publicado: (2015)

Bridging and downstaging role of trans-arterial radio-embolization for expected small remnant volume before liver resection for hepatocellular carcinoma
por: Shehta, Ahmed, et al.
Publicado: (2020)

Corrigendum: Bridging and downstaging role of trans-arterial radio-embolization for expected small remnant volume before liver resection for hepatocellular carcinoma
por: Shehta, Ahmed, et al.
Publicado: (2021)

Fatigue and related factors after liver transplantation
por: Hong, Kwangpyo, et al.
Publicado: (2015)

Prognosis of Hepatocellular Carcinoma after Liver Transplantation: Comparative Analysis with Partial Hepatectomy
por: Lee, Kyuho, et al.
Publicado: (2017)

Memory T cells are significantly increased in rejected liver allografts of rhesus monkeys
por: Kim, Hwajung, et al.
Publicado: (2018)

Early disseminated recurrence after liver resection in solitary hepatocellular carcinoma
por: Kim, Jong Man, et al.
Publicado: (2018)

Progression of a persisting mesenchymal hamartoma to intrahepatic cholangiocarcinoma 24 years after the initial diagnosis: A case report
por: Gang, Sujin, et al.
Publicado: (2022)

The Model for End-Stage Liver Disease Score-Based System Predicts Short Term Mortality Better Than the Current Child-Turcotte-Pugh Score-Based Allocation System during Waiting for Deceased Liver Transplantation
por: Hong, Geun, et al.
Publicado: (2013)

T-cell immune regulator 1 enhances metastasis in hepatocellular carcinoma
por: Yang, Hee Doo, et al.
Publicado: (2018)

Preoperative Selective Desensitization of Live Donor Liver Transplant Recipients Considering the Degree of T Lymphocyte Cross-Match Titer, Model for End-Stage Liver Disease Score, and Graft Liver Volume
por: Hong, Geun, et al.
Publicado: (2014)

Heterogeneous living donor hepatic fat distribution on MRI chemical shift imaging
por: Choi, YoungRok, et al.
Publicado: (2015)

Impact of tumor size on hepatectomy outcomes in hepatocellular carcinoma: a nationwide propensity score matching analysis
por: Hong, Suk Kyun, et al.
Publicado: (2022)

Histopathologic factors affecting tumor recurrence after hepatic resection in colorectal liver metastases
por: Park, Min-Su, et al.
Publicado: (2014)

Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In Vivo
por: Mussin, Nadiar, et al.
Publicado: (2017)

Outcomes of Living Donor Liver Transplantation in Patients With a History of Ruptured Hepatocellular Carcinoma
por: Lee, Hwi Yeol, et al.
Publicado: (2021)

Living donor liver transplantation should be cautiously considered as initial treatment in recurrent hepatocellular carcinoma within the Milan criteria after curative liver resection
por: Kim, Jong Man, et al.
Publicado: (2020)

Predicting prognosis and evaluating the benefits of adjuvant chemotherapy depending on the tumor location in intrahepatic cholangiocarcinoma: focusing on the involvement of below 2nd bile duct confluence
por: Sohn, Hee Ju, et al.
Publicado: (2022)

Sirolimus Prolongs Survival after Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond Milan Criteria: A Prospective, Randomised, Open-Label, Multicentre Phase 2 Trial
por: Lee, Kwang-Woong, et al.
Publicado: (2020)

Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence
por: Kang, Seong Hee, et al.
Publicado: (2018)

Alteration of MRP2 expression and the graft outcome after liver transplantation
por: Yi, Nam-Joon, et al.
Publicado: (2018)

Recurrence in patients with totally necrotic nodules of hepatocellular carcinoma after liver transplantation: “totally” an inaccurate description
por: Kim, Jiyoung, et al.
Publicado: (2023)

Nuclear Expression of Hepatitis B Virus X Protein Is Associated with Recurrence of Early-Stage Hepatocellular Carcinomas: Role of Viral Protein in Tumor Recurrence
por: Jin, Jing, et al.
Publicado: (2016)

Efficacy of Liver Resection for Single Large Hepatocellular Carcinoma in Child-Pugh A Cirrhosis: Analysis of a Nationwide Cancer Registry Database
por: Hong, Suk Kyun, et al.
Publicado: (2021)

Exophytic combined hepatocellular carcinoma and cholangiocarcinoma
por: Noh, Sang Jae, et al.
Publicado: (2012)

Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria
por: Cho, Yuri, et al.
Publicado: (2017)

Does living liver donors’ underestimation about surgical outcomes impact on their health-related quality of life after donation?: a descriptive cross-sectional study
por: Lee, Ye Sol, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3f5msbm1tr187uj1qtmndpi431